D-0493-2026 Class II Ongoing
FDA drug recall D-0493-2026 was initiated by The Harvard Drug Group LLC on Apr 9, 2026 and is designated Class II. Reason for recall: Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells. The recall status is ongoing. Affected quantity: 2,238 5 x 10 unit dose cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 29, 2026
- Initiation Date
- Apr 9, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,238 5 x 10 unit dose cartons
Product description
Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46288. NDC: 0904-7495-06
Reason for recall
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
Distribution pattern
Nationwide in the USA
Code information
Lot#: Lot N02406, Exp 10/31/2026; Lot N02845, Exp 12/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0493-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026